Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer

NCT02088710 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2017-09-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the role of patients' response expectations for nocebo side effects, quality of life and adherence during adjuvant endocrine treatment (AET). Furthermore, this study analyses the effects of a structured treatment information on patients' satisfaction with information, response expectations, knowledge and adherence.

Conditions

  • Female Breast Cancer

Interventions

BEHAVIORAL

Enhanced information about endocrine therapy

Enhanced information about endocrine therapy, extending clinical routine information

Sponsors & Collaborators

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Yvonne Nestoriuc, Prof. Dr. · Universitätsklinikum Hamburg-Eppendorf

  • Winfried Rief, Prof. Dr. · Philipps University Marburg

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-12-31
Completion
2020-02-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02088710 on ClinicalTrials.gov